United States · FDA National Drug Code directory
MiraLAX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11523-7268_51040c1b-71bf-bb83-e063-6294a90aca4e
- Product NDC
- 11523-7268
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Polyethylene Glycol 3350
- Labeler
- Bayer HealthCare LLC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20070201
- Source listing expiry
- 20271231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 10 PACKET in 1 CARTON (11523-7268-3) / 17 g in 1 PACKET · 11523-7268-3
- 765 g in 1 BOTTLE, PLASTIC (11523-7268-4) · 11523-7268-4
- 850 g in 1 BOTTLE, PLASTIC (11523-7268-5) · 11523-7268-5
- 24 PACKET in 1 CARTON (11523-7268-8) / 17 g in 1 PACKET · 11523-7268-8
- 20 POUCH in 1 CARTON (11523-7268-9) / 17 g in 1 POUCH · 11523-7268-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →